Skip to main content
Top
Published in: Critical Care 2/2002

01-04-2002 | Commentary

Red man syndrome

Authors: Soupramanien Sivagnanam, Dirk Deleu

Published in: Critical Care | Issue 2/2002

Login to get access

Abstract

Vancomycin can cause two types of hypersensitivity reactions, the red man syndrome and anaphylaxis. Red man syndrome has often been associated with rapid infusion of the first dose of the drug and was initially attributed to impurities found in vancomycin preparations. Even after improvement in vancomycin's purity, however, reports of the syndrome persist. Other antibiotics (e.g. ciprofloxacin, amphotericinB, rifampicin and teicoplanin) or other drugs that stimulate histamine release can result in red man syndrome. Discontinuation of the vancomycin infusion and administration of diphenhydramine can abort most of the reactions. Slow intravenous administration of vancomycin should minimize the risk of infusion-related adverse effects.
Literature
1.
go back to reference Eggimann P, Pittet D: Infection control in the ICU. Chest 2001, 120: 2059-2093. 10.1378/chest.120.6.2059CrossRefPubMed Eggimann P, Pittet D: Infection control in the ICU. Chest 2001, 120: 2059-2093. 10.1378/chest.120.6.2059CrossRefPubMed
2.
go back to reference Lori WaznyD, Behnam D: Desensitization protocols for vancomycin hypersensitivity. Ann Pharmacother 2001, 35: 1458-1464. 10.1345/1542-6270(2001)035<1458:DPFVH>2.0.CO;2CrossRef Lori WaznyD, Behnam D: Desensitization protocols for vancomycin hypersensitivity. Ann Pharmacother 2001, 35: 1458-1464. 10.1345/1542-6270(2001)035<1458:DPFVH>2.0.CO;2CrossRef
3.
go back to reference Davis RL, Smith AL, Koup JR: The 'red man's syndrome' and slow infusion of vancomycin [letter]. Ann Intern Med 1986, 104: 285-286.CrossRefPubMed Davis RL, Smith AL, Koup JR: The 'red man's syndrome' and slow infusion of vancomycin [letter]. Ann Intern Med 1986, 104: 285-286.CrossRefPubMed
4.
go back to reference Wilson APR: Comparative safety of teicoplanin and vancomycin. Int J Antimicrobial Agents 1998, 10: 143-152. 10.1016/S0924-8579(98)00025-9CrossRef Wilson APR: Comparative safety of teicoplanin and vancomycin. Int J Antimicrobial Agents 1998, 10: 143-152. 10.1016/S0924-8579(98)00025-9CrossRef
5.
go back to reference Renz CL, Thurn JD, Finn HA, Lynch JP, Moss J: Clinical investigations: antihistamine prophylaxis permits rapid vancomycin infusion. Crit Care Med 1999, 27: 1732-1737. 10.1097/00003246-199909000-00006CrossRefPubMed Renz CL, Thurn JD, Finn HA, Lynch JP, Moss J: Clinical investigations: antihistamine prophylaxis permits rapid vancomycin infusion. Crit Care Med 1999, 27: 1732-1737. 10.1097/00003246-199909000-00006CrossRefPubMed
6.
go back to reference Korman T, Turnidge J, Grayson M: Risk factors for cutaneous reactions associated with intravenous vancomycin. J Antimicrob Chemother 1997, 39: 371-381.CrossRefPubMed Korman T, Turnidge J, Grayson M: Risk factors for cutaneous reactions associated with intravenous vancomycin. J Antimicrob Chemother 1997, 39: 371-381.CrossRefPubMed
7.
go back to reference Bergeron L, Boucher F: Possible red-man syndrome associated with systemic absorption of oral vancomycin in a child with normal renal function. Ann Pharmacother 1994, 28: 581-584.PubMed Bergeron L, Boucher F: Possible red-man syndrome associated with systemic absorption of oral vancomycin in a child with normal renal function. Ann Pharmacother 1994, 28: 581-584.PubMed
8.
go back to reference Williams PD, Laska DA, Shetler TJ, McGrath JP, White SL, Hoover DM: Vancomycin-induced release of histamine from rat peritoneal mast cells and a rat basophil cell line (RBL-1). Agents Actions 1991, 32: 217-223.CrossRefPubMed Williams PD, Laska DA, Shetler TJ, McGrath JP, White SL, Hoover DM: Vancomycin-induced release of histamine from rat peritoneal mast cells and a rat basophil cell line (RBL-1). Agents Actions 1991, 32: 217-223.CrossRefPubMed
9.
go back to reference Renz CL, Laroche D, Thurn JD, Finn HA, Lynch JP, Thisted R, Moss J: Tryptase levels are not increased during vancomycin-induced anaphylactoid reactions. Anesthesiology 1998, 89: 620-625. 10.1097/00000542-199809000-00010CrossRefPubMed Renz CL, Laroche D, Thurn JD, Finn HA, Lynch JP, Thisted R, Moss J: Tryptase levels are not increased during vancomycin-induced anaphylactoid reactions. Anesthesiology 1998, 89: 620-625. 10.1097/00000542-199809000-00010CrossRefPubMed
11.
go back to reference Wallace M, Mascola J, Oldfiels E Ill: Red-man syndrome: Incidence, etiology, and prophylaxis. J Infect Dis 1991, 164: 1180-1185.CrossRefPubMed Wallace M, Mascola J, Oldfiels E Ill: Red-man syndrome: Incidence, etiology, and prophylaxis. J Infect Dis 1991, 164: 1180-1185.CrossRefPubMed
12.
go back to reference Polk RE, Healy DP, Schwartz LB, Rock DT, Garson ML, Roller K: Vancomycin and the red-man syndrome: pharmacodynamics of histamine release. J Infect Dis 1988, 157: 502-507.CrossRefPubMed Polk RE, Healy DP, Schwartz LB, Rock DT, Garson ML, Roller K: Vancomycin and the red-man syndrome: pharmacodynamics of histamine release. J Infect Dis 1988, 157: 502-507.CrossRefPubMed
13.
go back to reference Healy DP, Sahai JV, Fuller SH, Polk RE: Vancomycin-induced histamine release and 'red man syndrome": comparison of 1- and 2-hour infusions. Antimicrob Agents Chemother 1990, 34: 550-554.PubMedCentralCrossRefPubMed Healy DP, Sahai JV, Fuller SH, Polk RE: Vancomycin-induced histamine release and 'red man syndrome": comparison of 1- and 2-hour infusions. Antimicrob Agents Chemother 1990, 34: 550-554.PubMedCentralCrossRefPubMed
14.
go back to reference Wilson APR: Comparative safety of teicoplanin and vancomycin. Int J Antimicrobial Agents 1998, 10: 143-152. 10.1016/S0924-8579(98)00025-9CrossRef Wilson APR: Comparative safety of teicoplanin and vancomycin. Int J Antimicrobial Agents 1998, 10: 143-152. 10.1016/S0924-8579(98)00025-9CrossRef
15.
go back to reference Sahai J, Healy DP, Garris R, Berry A, Polk RE: Influence of antihistamine pre-treatment on vancomycin induced red-man syndrome. J Infect Dis 1989, 160: 876-881.CrossRefPubMed Sahai J, Healy DP, Garris R, Berry A, Polk RE: Influence of antihistamine pre-treatment on vancomycin induced red-man syndrome. J Infect Dis 1989, 160: 876-881.CrossRefPubMed
16.
go back to reference Wallace MR, Mascola JR, Oldfield EC: Red man syndrome: incidence, aetiology and prophylaxis. J Infect Dis 1991, 164: 1180-1185.CrossRefPubMed Wallace MR, Mascola JR, Oldfield EC: Red man syndrome: incidence, aetiology and prophylaxis. J Infect Dis 1991, 164: 1180-1185.CrossRefPubMed
17.
go back to reference Miller R, Tausk HC: Anaphylactoid reaction to vancomycin during anaesthesia: a case report. Anest Analg 1977, 56: 870-872.CrossRef Miller R, Tausk HC: Anaphylactoid reaction to vancomycin during anaesthesia: a case report. Anest Analg 1977, 56: 870-872.CrossRef
18.
go back to reference Southorn PA, Plevak DJ, Wright AJ, Wilson WR: Adverse effects of vancomycin administered in the perioperative period. Mayo Clin Proc 1986, 61: 721-724.CrossRefPubMed Southorn PA, Plevak DJ, Wright AJ, Wilson WR: Adverse effects of vancomycin administered in the perioperative period. Mayo Clin Proc 1986, 61: 721-724.CrossRefPubMed
19.
go back to reference Massimo B, Flavio B, Roberta C, Carlo C, Francesco G: Pruritus: a useful sign for predicting the haemodynamic changes that occur following administration of vancomycin. Crit Care 2002, 6: 234-239. 10.1186/cc1495CrossRef Massimo B, Flavio B, Roberta C, Carlo C, Francesco G: Pruritus: a useful sign for predicting the haemodynamic changes that occur following administration of vancomycin. Crit Care 2002, 6: 234-239. 10.1186/cc1495CrossRef
20.
go back to reference Wilhelm MP, Estes LPD: Symposium on Antimicrobial Agents – Part XII. Vancomycin. Mayo Clin Proc 1999, 74: 928-935.CrossRefPubMed Wilhelm MP, Estes LPD: Symposium on Antimicrobial Agents – Part XII. Vancomycin. Mayo Clin Proc 1999, 74: 928-935.CrossRefPubMed
Metadata
Title
Red man syndrome
Authors
Soupramanien Sivagnanam
Dirk Deleu
Publication date
01-04-2002
Publisher
BioMed Central
Published in
Critical Care / Issue 2/2002
Electronic ISSN: 1364-8535
DOI
https://doi.org/10.1186/cc1871

Other articles of this Issue 2/2002

Critical Care 2/2002 Go to the issue